22, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company ... a spotlight presentation at the San Antonio Breast Cancer Symposium 2020 in December.
News
- Immutep Quarterly Activities Report
- Express Briefing: Why vaccine distribution is so difficult
Dr. Joanne Turner, a scientist who serves as Texas Biomedical Research Institute's vice president for research, to learn more about how vaccines are ...
- Ousted Thai politician defends vaccine procurement criticism
Later this year, Siam Bioscience is to produce 200 million doses of the vaccine developed by Oxford University and the pharmaceutical company ...
- Oxygen-starved city in Brazil's Amazon starts immunization
... is the first woman to receive the COVID-19 vaccine produced by China's Sinovac Biotech Ltd, during the start of the vaccination program in Manaus, ...
- New institute to leverage experts to advance regenerative medicine
... in San Antonio in the areas of regenerative medicine, precision therapeutics, tissue engineering, stem cell biology and related biotechnology.